PRKCB and nasopharyngeal carcinoma: To validate the relationship between expression of gene and methylation of its promoter in NPC, we examined the expression levels of PRKCB before and after treatment with the demethylating drug DAC using human nasal epithelial cells (hNEpC) and NPC cell line C666-1 (see Methods).